Phlexglobal: PharmaLex expands global footprint capabilities for clinical and regulatory services with Phlexglobal merger

Merger continues commitment to innovation and strengthens tech-enablement and automation Frankfurt, Germany - 25 January 2022: PharmaLex Group, a leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has announced a merger with leading technology and services organization for clinical and regulatory solutions, Phlexglobal. Founded in 1997, Phlexglobal provides its industry-leading and innovative electronic Trial M...